— After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). — After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly insulin analog GZR4 injection demonstrated superior HbA1c reduction in […]

Cyngn Inc. (Nasdaq: CYN) today announced the expansion of its dealer network to include Raymond West. A leading distributor and integrator of intralogistics solutions, Raymond West will begin selling Cyngn’s autonomous DriveMod Tugger. The autonomous tuggerintegrates Cyngn’s AV technology with Motrec’s MT-160. https://mma.prnewswire.com/media/2530239/Raymond_West.jpg “With 21 branches across the West Coast, Raymond West is an impressive

Women are hot – very hot – and bothered that menopause remains poorly understood and deeply underfunded With more than 50 per cent of a Canadian woman’s lifetime spent inperimenopause, menopause and post menopause and an estimated $3.5 billion in national revenue lost annually due to unmanaged menopause symptoms, Sinai Health Foundation is taking a

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to report an increase in the Mineral Resource Estimate (Resource, Mineral Resource Estimate or MRE) and a Maiden Ore Reserve for its flagship copper-gold project at Kharmagtai, in the South Gobi region of Mongolia

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Amwell(R) (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the

NEW HAVEN, Conn., Oct. 15, 2024 (GLOBE NEWSWIRE) — Allyx Therapeutics announced today that it has been awarded a $3.3 million grant from the National Institutes of Health as part of its Small Business Innovation Research Commercial Readiness Pilot program. This funding will support further investigation of Allyx’s lead clinical asset, ALX-001, a highly-selective, first-in-class,

LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient has been dosed in the Phase I/II clinical trial of AMT-162 for the treatment of amyotrophic lateral sclerosis (ALS) caused by

Topline Results Expected in Q1 2025 Lutris Pharma, a clinical stage biopharmaceutical company focused onimprovinganti-cancertherapies byreducingcutaneous doselimiting toxicity, today announced that it has completed enrollment in the phase 2 trial of lead compound, LUT014, a topically-applied novel B-Raf inhibitor, for patients with metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor (EGFR) inhibitor therapy

Local home services provider to donate $50 to Seattle Children’s Hospital for each goal scored Harts Plumbers, Electricians & HVAC Technicians, a top-rated home services provider founded in 2013, remains dedicated to giving back to their local community by continuing its partnership with the Seattle Kraken, an alliance that helped generate $10,850 for Seattle Children’s

PETAH TIKVA, Israel, Oct. 15, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that it has been awarded approximately $15 million in orders from several major satellite operators for its advanced satellite communications solutions for GEO, MEO and LEO